CAS: 35793-73-8; Boc-D-Glu(Obzl)-Oh

该化合物是氨酸甲基甲酸酯的衍生物,在氨基酸组和碳酸箱酸组中,含有三丁基氧基碳酸(Boc)保护组和苯基(Bzl)酯(Bzl)酯.该化合物通常用于浸泡合成和有机化学,因其稳定性和易于操作而成为其组成部分.Boc组在合成过程中提供保护,防止不必要的反应,而苯基酯可以在温和的条件下有选择地去除,允许进一步的功能化.D组分表明,它是一种可影响其生物活动和相互作用的甲基丙基酸的立体异构体.该化合物通常在有机溶剂中溶解,其再活性可以通过去除保护组来调整,使其在合成更复杂的分子时成为多功能的中间体.应当注意到,由于使用所有化学物质具有潜在危险,因此,应注意安全并处理各种防范措施.

结构式图片

相似化合物

117997-81-6 123639-61-2 13574-13-5

上下游产品

CAS号16965-08-5 碳酸叔丁基-2,4,5-三氯苯酯 | CAS号2578-33-8 D-谷氨酸-5-苄酯 | CAS号6893-26-1 D-谷氨酸 | CAS号24424-99-5 二碳酸二叔丁酯 | CAS号100-51-6 苯甲醇 | CAS号41840-28-2 S-B°C-2-巯基-4,6-二甲基嘧啶 | CAS号870-46-2 肼基甲酸叔丁酯 | CAS号1070-19-5 Carbonazidic ac... | CAS号55297-72-8 N-叔丁氧羰基-D-异谷氨酰胺 | CAS号292150-20-0 FM°C-alpha-谷氨酸盐 | CAS号19522-40-8 (R)-4,5-二氨基-5-氧代戊酸 | CAS号18814-49-8 (R)-5-氨基-4-((S)... | CAS号45159-25-9 H-Ala-D-Glu-NH2 | CAS号55227-00-4 (R)-4-((叔丁氧基羰基)...

合成工艺路线路线简述

    D-谷氨酸置于硫酸体系中,化学反应生成 Boc-D-谷氨酸-5-苄酯
    参考文献:使用多销方法固相合成穆拉基二肽(mdp)衍生物.
    标题:使用多销方法固相合成穆拉基二肽(mdp)衍生物.
    摘要:报道了固相合成穆拉基二肽衍生物的方法.基于此药物筛选方法,可以通过酰化,还原烷基化,磺酰胺形成,尿素形成,N-烷基化,胺加成或组分ugi反应潜在地合成多样的穆拉基二肽文库.
    DOI:10.1016/s0960-894X(00)00241-9

    海关参考信息

    专利信息


    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-10927147-B2
    优先权日:2015-12-10
    标 题:Muramyl peptide derivative compound, synthesis and uses thereof
    发明人:ELLA KRISHNA MURTHY; BRUNDA GANNERU; KUMAR HALMATHUR MAHABALARAO SAMPATH; SREEKANTH MIRYALA
    权利人:BHARAT BIOTECH INT LTD; COUNCIL SCIENT IND RES
    摘要:The invention relates to novel Muramyl Dipeptide (MDP) derivative compound of structural Formula-VIII, a process for synthesis, intermediates used in the synthesis and use thereof. n n n n n n n n n n Wherein, R can be both linear and branched alkyl, aryl, substituted aryl and alkoxy alkyl. These compounds possess excellent pharmacological properties, in particular immunomodulating properties for use as adjuvant in vaccine formulations. These compounds are, particularly useful as adjuvants in vaccines.

    专利号:US-9085605-B2
    优先权日:2010-05-27
    标 题:Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate
    发明人:LIU GANG; ZHAO NAN; MA YAO
    权利人:LIU GANG; ZHAO NAN; MA YAO; SHENZHEN SALUBRIS PHARM CO LTD
    摘要:The present invention discloses chemical synthesis, anti-tumor and anti-metastatic effects of a dual functional conjugate as shown by formula I. Specifically, paclitaxel or docetaxol is linked with muramyl dipeptide derivative to form a conjugate, thus dual anti-tumor and anti-metastatic effects are achieved by combination of chemotherapy and immunotherapy. The present invention also discloses that paclitaxel or docetaxol and muramyl dipeptide derivative conjugate is synthesized by combination of solid-phase and solution-phase synthesis, and said conjugate can be used in manufacture of anti-tumor medicaments as proved by reliable bioassays.

    专利号:US-10576147-B2
    优先权日:2015-12-15
    标题:Muramyl peptide derivative compound, synthesis and uses thereof
    发明人:ELLA KRISHNA MURTHY; BRUNDA GANNERU; KUMAR HALMATHUR MAHABALARAO SAMPATH; SREEKANTH MIRYALA
    权利人:BHARAT BIOTECH INT LTD; COUNCIL SCIENT IND RES
    摘要:The invention relates to novel Muramyl Dipeptide (MDP) derivative compound of structural Formula-VIII, a process for synthesis, intermediates used in the synthesis and use thereof; n nwherein R 1 and R 2 both are hydrogen; or R 1 is hydrogen and R 2 is alkyl or aryl; or R 1 is alkyl or aryl and R 2 is hydrogen; or R 1 and R 2 both are alkyl or aryl (same or different groups); wherein alkyl group constitute C1-C6 alkyl or higher (both linear and branched) with or without heteroatoms; and aryl group constitute phenyl, substituted phenyl, heteraryl, arylalkyl and polynuclear aromatics. These compounds possess excellent pharmacological properties, in particular immunomodulating properties for use as adjuvant in vaccine formulations. These compounds are, particularly useful as adjuvants in vaccines.

    专利号:US-12134664-B2
    优先权日:2015-12-10
    标 题:Muramyl peptide derivatives
    发明人:ELLA KRISHNA MURTHY; BRUNDA GANNERU; KUMAR HALMUTHUR MAHABALARAO SAMPATH; REDDY PATURU RAMA SUBBA
    权利人:BHARAT BIOTECH INT LTD; COUNCIL SCIENT IND RES; BHARAT BIOTECH INT LTD
    摘要:The invention is directed to Muramyl Dipeptide (MDP) derivative compounds of structural Formula-VIII, a process for synthesis, intermediates used in the synthesis and use thereof: n nwherein, R can be a linear or branched alkyl, an aryl, a substituted aryl, or an alkoxy alkyl. These compounds possess excellent pharmacological properties, in particular immunomodulating properties for use as adjuvant in vaccine formulations. These compounds are particularly useful as adjuvants in vaccines.

    专利号:EP-3239139-B1
    优先权日:2010-05-27
    标题 :Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate
    四川嘉瑛莱科技有限责任公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jiayinglai.com/
    电话: 028-64159575👤
    📞四川嘉瑛莱科技有限责任公司 ⚠️参考联系方式

    销售电话:028-64159575
    邮箱:linda@enlaibio.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知